Delivery Order SPE2DE21D0007-SPE2D625F4JA8
- Not listed
- This is a $1,832.54 delivery order awarded by the Medical Supply Chain, a division of the Defense agency, to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The contract is for the supply of "ANTI-A BIOCLONE 15X10ML", a medical diagnostic product, with a period of performance through May 2025. The contract has a fixed price with economic price adjustment pricing type and does not utilize any set-aside designations. Ortho-Clinical Diagnostics, Inc. is a...
- This is a $1,156.61 fixed-price delivery order awarded to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, by the Medical Supply Chain unit of the Defense Department. The award is for the supply of ANTI-A BIOCLONE 15X10ML medical products. The contract has a completion date of July 25, 2025 and does not utilize any set-aside designations, indicating open competition. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture and has previously held...
- This is a federal contract award to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, to provide anti-A bioclone 15x10mL to a U.S. government agency. The contract has a ceiling value of $1,497.37 and is a delivery order with a fixed price and economic price adjustment. The ultimate completion date is February 28, 2025, and the award date is February 25, 2025. The contract does not have a set-aside designation, indicating open competition. The awarding agency is the...
- This is a federal contract award to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, for the delivery of anti-A bioclone 15x10ml. The contract was awarded by the Medical Supply Chain, a component of the Defense agency, and has a ceiling value of $1,832.54. The contract is a Delivery Order with a fixed price and economic price adjustment pricing type, and has an ultimate completion date of April 28, 2025. The contract does not have a set-aside designation, indicating...
- This is a federal delivery order contract awarded by the Medical Supply Chain, a division of the Defense Logistics Agency, to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The contract, valued at $1,832.54, is for the delivery of ANTI-A BIOCLONE 15X10ML medical supplies. The contract has a fixed price with economic price adjustment pricing structure and an ultimate completion date of August 29, 2024. There is no set-aside designation mentioned in the...
- This is a fixed-price delivery order awarded by the Defense Health Agency to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The $2,111.62 contract is for the provision of "ANTI-A BIOCLONE 15X10ML" medical supplies. The company is a self-certified HUBZone joint venture, indicating the contract did not utilize a small business set-aside. Ortho-Clinical Diagnostics is an experienced federal contractor, holding multiple Indefinite Delivery Contracts and...
- This is a $1,832.54 fixed-price delivery order contract awarded to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, by the Medical Supply Chain, an alternate name for the Defense Health Agency. The contract is for the supply of ANTI-A BIOCLONE 15X10ML medical supplies. It does not utilize any set-aside designations, indicating open competition. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture and has a demonstrated history of providing...
- This federal contract award, valued at $1,832.54, was issued by the Medical Supply Chain division of the Defense agency to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The contract is for the delivery of 4567190755 ANTI-B BIOCLONE 15X10ML, a critical medical diagnostic product. It is a fixed price delivery order with economic price adjustment, with a completion date of February 12, 2025. No set-aside designation was used, indicating open competition....
- This federal contract award, identified as SPE2DE21D0007|SPE2D625F1R4B, was issued by the Medical Supply Chain, a component of the Defense agency, to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The $1,832.54 fixed-price contract with economic price adjustment is for the delivery of "ANTI-A BIOCLONE 15X10ML" medical supplies. This appears to be a delivery order under a larger contract vehicle, as the award notice references Ortho-Clinical...
- This is a delivery order awarded by the Defense Logistics Agency Troop Support Medical to Ortho-Clinical Diagnostics Inc., a for-profit manufacturer of medical equipment and diagnostics. The contract is for the delivery of an ANTI-A BIOCLONE 15X10ML product, with a completion date of December 27, 2023 and a potential value of $4,581.35. The contract type is Fixed Price with Economic Price Adjustment. Ortho-Clinical Diagnostics Inc. has previously provided a range of medical equipment,...
- SPE2DE21D0007Indefinite Delivery Contract
- SPE2DE21D0007-SPE2D625F4JA8Delivery Order
This is a federal contract award to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, by a U.S. government agency. The contract is for the delivery of "ANTI-A BIOCLONE 15X10ML" medical supplies. The contract is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing type, a ceiling value of $1,871.28, and an ultimate completion date of July 3, 2025. The contract is not designated as a set-aside. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture based in Raritan, New Jersey. The funding agency is the Medical Supply Chain, which is an alternate name for a defense agency. The contract appears to be part of the Critical Analyzers, Laboratory (FSS-66-III) GSA Schedule, providing medical diagnostic equipment and related supplies to federal healthcare agencies such as the Department of Veterans Affairs, Indian Health Service, and Defense Health Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 6/30/25 |